CHALLENGES OF NETWORK META-ANALYSIS FOR SAFETY OUTCOMES: THE ANALYSIS OF TIRBANIBULIN AGAINST COMMON TREATMENTS IN EUROPE FOR ACTINIC KERATOSIS

Heppt M, Dykukha I, Chapman-Rounds M, Graziadio S, Edwards M (2022)

Publication Type: Conference contribution

Publication year: 2022

Journal

Value in Health Wiley-Blackwell: No OnlineOpen / Elsevier

Publisher: ELSEVIER SCIENCE INC

City/Town: NEW YORK

Pages Range: S351-S351

Conference Proceedings Title: VALUE IN HEALTH

DOI: 10.1016/j.jval.2022.09.1740

Authors with CRIS profile

Markus Heppt Department of Dermatology

Involved external institutions

Almirall Hermal GmbH DE Germany (DE) York Health Economics Consortium Ltd. (YHEC) GB United Kingdom (GB)

How to cite

APA:

Heppt, M., Dykukha, I., Chapman-Rounds, M., Graziadio, S., & Edwards, M. (2022). CHALLENGES OF NETWORK META-ANALYSIS FOR SAFETY OUTCOMES: THE ANALYSIS OF TIRBANIBULIN AGAINST COMMON TREATMENTS IN EUROPE FOR ACTINIC KERATOSIS. In VALUE IN HEALTH (pp. S351-S351). NEW YORK: ELSEVIER SCIENCE INC.

MLA:

Heppt, Markus, et al. "CHALLENGES OF NETWORK META-ANALYSIS FOR SAFETY OUTCOMES: THE ANALYSIS OF TIRBANIBULIN AGAINST COMMON TREATMENTS IN EUROPE FOR ACTINIC KERATOSIS." Proceedings of the VALUE IN HEALTH NEW YORK: ELSEVIER SCIENCE INC, 2022. S351-S351.

BibTeX: Download